Literature DB >> 27607858

Burch Retropubic Urethropexy Compared With Midurethral Sling With Concurrent Sacrocolpopexy: A Randomized Controlled Trial.

Emanuel C Trabuco1, Christopher J Klingele, Roberta E Blandon, John A Occhino, Amy L Weaver, Michaela E McGree, Maureen A Lemens, John B Gebhart.   

Abstract

OBJECTIVE: To compare efficacy and safety of retropubic Burch urethropexy and a midurethral sling in women with stress urinary incontinence (SUI) undergoing concomitant pelvic floor repair with sacrocolpopexy.
METHODS: Women were randomly assigned to Burch retropubic urethropexy (n=56) or retropubic midurethral sling (n=57) through dynamic allocation balancing age, body mass index, history of prior incontinence surgery, intrinsic sphincter deficiency, preoperative incontinence diagnosis, and prolapse stage. Overall and stress-specific continence primary outcomes were ascertained with validated questionnaires and a blinded cough stress test.
RESULTS: Enrollment was June 1, 2009, through August 31, 2013. At 6 months, no difference was found in overall (29 midurethral sling [51%] compared with 23 Burch [41%]; P=.30) (odds ratio [OR] 1.49, 95% confidence interval [CI] 0.71-3.13) or stress-specific continence rates (42 midurethral sling [74%] compared with 32 Burch [57%]; P=.06) (OR 2.10, 95% CI 0.95-4.64) between groups. However, the midurethral sling group reported greater satisfaction (78% compared with 57%; P=.04) and were more likely to report successful surgery for SUI (71% compared with 50%; P=.04) and to resolve pre-existing urgency incontinence (72% compared with 41%; P=.03). No difference was found in patient global impression of severity or symptom improvement, complication rates, or mesh exposures.
CONCLUSION: There was no difference in overall or stress-specific continence rates between midurethral sling and Burch urethropexy groups at 6 months. However, the midurethral sling group reported better patient-centered secondary outcomes.

Entities:  

Mesh:

Year:  2016        PMID: 27607858      PMCID: PMC5035209          DOI: 10.1097/AOG.0000000000001651

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  28 in total

1.  Procedures for pelvic organ prolapse in the United States, 1979-1997.

Authors:  Sarah Hamilton Boyles; Anne M Weber; Leslie Meyn
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

2.  The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.

Authors:  R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith
Journal:  Am J Obstet Gynecol       Date:  1996-07       Impact factor: 8.661

3.  Effect of Transobturator Midurethral Sling Placement on Urgency and Urge Incontinence: 1-Year Outcomes.

Authors:  Joseph R Habibi; Albert Petrossian; David E Rapp
Journal:  Female Pelvic Med Reconstr Surg       Date:  2015 Sep-Oct       Impact factor: 2.091

4.  Burch colposuspension: a 10-20 year follow up.

Authors:  M Alcalay; A Monga; S L Stanton
Journal:  Br J Obstet Gynaecol       Date:  1995-09

5.  Predicting the number of women who will undergo incontinence and prolapse surgery, 2010 to 2050.

Authors:  Jennifer M Wu; Amie Kawasaki; Andrew F Hundley; Alexis A Dieter; Evan R Myers; Vivian W Sung
Journal:  Am J Obstet Gynecol       Date:  2011-04-02       Impact factor: 8.661

6.  Validation of the overactive bladder symptom score.

Authors:  Jerry G Blaivas; Georgia Panagopoulos; Jeffrey P Weiss; Chandra Somaroo
Journal:  J Urol       Date:  2007-06-14       Impact factor: 7.450

7.  Signs of genital prolapse in a Swedish population of women 20 to 59 years of age and possible related factors.

Authors:  E C Samuelsson; F T Victor; G Tibblin; K F Svärdsudd
Journal:  Am J Obstet Gynecol       Date:  1999-02       Impact factor: 8.661

8.  Prospective multicentre randomised trial of tension-free vaginal tape and colposuspension as primary treatment for stress incontinence.

Authors:  Karen Ward; Paul Hilton
Journal:  BMJ       Date:  2002-07-13

9.  Abdominal sacral colpopexy or vaginal sacrospinous colpopexy for vaginal vault prolapse: a prospective randomized study.

Authors:  Christopher F Maher; Aymen M Qatawneh; Peter L Dwyer; Marcus P Carey; Ann Cornish; Philip J Schluter
Journal:  Am J Obstet Gynecol       Date:  2004-01       Impact factor: 8.661

Review 10.  The method of minimization for allocation to clinical trials. a review.

Authors:  Neil W Scott; Gladys C McPherson; Craig R Ramsay; Marion K Campbell
Journal:  Control Clin Trials       Date:  2002-12
View more
  3 in total

1.  A comprehensive look at risk factors for mid-urethral sling revision surgery.

Authors:  Melissa Keslar; Haroutyoun Margossian; Justin E Katz; Nisha Lakhi
Journal:  Int Urogynecol J       Date:  2020-02-07       Impact factor: 2.894

2.  Two-Year Results of Burch Compared With Midurethral Sling With Sacrocolpopexy: A Randomized Controlled Trial.

Authors:  Emanuel C Trabuco; Brian J Linder; Christopher J Klingele; Roberta E Blandon; John A Occhino; Amy L Weaver; Michaela E McGree; John B Gebhart
Journal:  Obstet Gynecol       Date:  2018-01       Impact factor: 7.661

3.  Robotic-assisted Sacrocolpopexy with versus without Concomitant Midurethral Sling: A 2-year Follow-up of Urinary Symptoms and Quality of Life.

Authors:  Jeffrey S Schachar; Kathryn S Williams; Harvey A Winkler
Journal:  J Midlife Health       Date:  2018 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.